Development of utrophin modulators for the treatment of Duchenne Muscular Dystrophy


Developing small molecules for the treatment of age-related diseases


New agents for tumour detection and therapy


Development of anti-inflammatory agents

Welcome to the Russell Group webpages. The Russell Group is based in the Department of Chemistry and the Department of Pharmacology at the University of Oxford. Explore our website to learn more about our group, collaborative research programmes and publications.

Latest news
Stacks Image 283
Bronze award for Isabel Wilkinson at the STEM for Britain reception 2019

Many congratulations to Isabel who was awarded the Bronze award (Chemistry section) for her poster at the STEM for Britain exhibition at the House of Commons on Wednesday 13th March. STEM for BRITAIN aims to raise the profile of Britain's early-stage researchers at Westminster by engaging Members of both Houses of Parliament with current science, engineering and mathematics research being undertaken in the UK. Isabel presented her research on identifying drug targets for Duchenne Muscular Dystrophy, a project in collaboration with Prof Dame Kay Davies (DPAG) and Dr Kilian Huber (Nuffield Department of Medicine). Read the full press release.
Publication highlights

Nature Comms paper highlights a new strategy for targeting protein-protein interactions (PPIs) for the development of new small molecule therapeutics.

Results from a collaboration between the Rabbitts Group (MRC Weatherall Institute of Molecular Medicine, WIMM) and the Russell group (Depts Chemistry and Pharmacology) has recently been published in Nature Communications.

Read more…